バイオ医薬品発酵システム市場：製品、用途、エンドユーザー別-2025-2030年の世界予測

バイオ医薬品発酵システム市場は、2023年に156億5,000万米ドルと評価され、2024年には168億6,000万米ドルに達すると予測され、CAGR 7.82％で成長し、2030年には265億2,000万米ドルに達すると予測されています。

バイオ医薬品発酵システム市場には、主に微生物や細胞ベースの発酵プロセスを通じてバイオ医薬品を生産する際に使用される技術や装置が含まれます。これらのシステムは、制御された微生物増殖を促進することにより、ワクチン、モノクローナル抗体、組換えタンパク質を含む生物製剤の大量生産に不可欠です。発酵システムの必要性は、化学的に合成できない複雑な生物学的に活性な製品を生産する上で、その重要な役割によって強調されています。アプリケーションには医薬品、バイオテクノロジー、飲食品、環境などがあり、エンドユーザーは製薬会社から製造受託機関、研究機関まで多岐にわたる。この市場に影響を与える主な成長要因としては、慢性疾患の増加や個別化医療への関心の高まりによるバイオ医薬品需要の増加が挙げられます。また、シングルユースシステムの革新とともに、バイオプロセス機器の技術的進歩も、より柔軟でコスト効率が高く、拡張性のあるソリューションを提供することで市場の成長を後押ししています。最新の潜在的ビジネスチャンスは、ヘルスケアインフラが整備されつつある新興国市場と、新規バイオシミラーおよび生物製剤の市場開拓にあります。しかし、高額な初期資本投資、厳しい規制要件、複雑な製造工程といった課題が、市場拡大に大きな制約を与えています。技術革新が必要な分野としては、効率的な下流工程技術の開発、プロセス分析技術（PAT）の改善、合成生物学による生物学的製剤の生産効率の向上などが挙げられます。発酵プロセスにおける自動化とデジタル化の調査も、事業成長の道筋を提供します。市場はダイナミックで、急速な技術進歩と、主要企業が研究開発に多額の投資を行っている競合情勢を特徴としています。企業は、より持続可能で効率的な発酵プロセスの開発に注力することで、より環境に優しいバイオマニュファクチャリング慣行への業界のシフトに合わせ、こうした動向を活用することができます。

市場力学：急速に進化するバイオ医薬品発酵システム市場の主要市場インサイトを公開

バイオ医薬品発酵システム市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • バイオ医薬品に対する需要の高まり
  • 慢性疾患の増加
  • バイオベースの生産工程における工業計測・モニタリング技術の発展
• 市場抑制要因
  • 製造に関連する高コストと厳しい規制要件
• 市場機会
  • 効率的で費用対効果の高い発酵システムを作るための新たな技術革新
  • 発酵技術の様々な分野における研究開発の活発化
• 市場の課題
  • バイオ医薬品発酵システムに対する認識と訓練された専門家の不足

ポーターの5つの力：バイオ医薬品発酵システム市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオ医薬品発酵システム市場における外部からの影響の把握

外部マクロ環境要因は、バイオ医薬品発酵システム市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析バイオ医薬品発酵システム市場における競合情勢の把握

バイオ医薬品発酵システム市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスバイオ医薬品発酵システム市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオ医薬品発酵システム市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨バイオ医薬品発酵システム市場における成功への道筋を描く

バイオ医薬品発酵システム市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • バイオテクノロジー医薬品の需要増加
    • 慢性疾患の発生率の増加
    • バイオベース生産プロセスのための産業計測・監視技術の開発
  • 抑制要因
    • 製造に関連する高コストと厳しい規制要件
  • 機会
    • 効率的で費用対効果の高い発酵システムを実現するための新たなイノベーション
    • 発酵技術のさまざまな分野における調査開発活動の増加
  • 課題
    • バイオ医薬品発酵システムに関する認識と訓練を受けた専門家が限られている
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 バイオ医薬品発酵システム市場：製品別

• 下流プロセス製品
  • クロマトグラフィーシステム
  • 消耗品とアクセサリー
  • 濾過・分離機器
• 上流プロセス製品
  • バイオリアクターまたは発酵槽
  • バッファ
  • メディアと文化の準備
  • プロセス監視システム

第7章 バイオ医薬品発酵システム市場：用途別

• 抗生物質
• モノクローナル抗体
• プロバイオティクス
• 組み換えタンパク質

第8章 バイオ医薬品発酵システム市場：エンドユーザー別

• バイオ医薬品企業
• 契約調査機関
• 食品産業
• 研究開発機関

第9章 南北アメリカのバイオ医薬品発酵システム市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のバイオ医薬品発酵システム市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのバイオ医薬品発酵システム市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• AntoXa Corporation
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• BioPharm Process Associates, LLC
• Danaher Corporation
• Eppendorf SE
• F. Hoffmann-La Roche AG
• GEA Group Aktiengesellschaft
• General Electric Company
• Lonza Group
• Merck KGaA
• Nova Biomedical Corporation
• Sartorius AG
• Thermo Fisher Scientific Inc.
• ZETA GmbH

LIST OF FIGURES

• FIGURE 1. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET RESEARCH PROCESS
• FIGURE 2. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET DYNAMICS
• TABLE 7. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY FILTRATION & SEPARATION INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BIOREACTORS OR FERMENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY MEDIA & CULTURE PREPARATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PROCESS MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY RESEARCH & DEVELOPMENT INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 188. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 238. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 239. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

The Biopharmaceutical Fermentation System Market was valued at USD 15.65 billion in 2023, expected to reach USD 16.86 billion in 2024, and is projected to grow at a CAGR of 7.82%, to USD 26.52 billion by 2030.

The biopharmaceutical fermentation system market encompasses technologies and equipment used in the production of biopharmaceuticals, primarily through microbial and cell-based fermentation processes. These systems are essential for the large-scale production of biologics, including vaccines, monoclonal antibodies, and recombinant proteins, by facilitating controlled microbial growth. The necessity of fermentation systems is underscored by their critical role in producing complex, biologically active products that cannot be synthesized chemically. Applications include pharmaceuticals, biotechnology, food & beverages, and the environment, with end-users spanning from pharmaceutical companies to contract manufacturing organizations and research institutes. Key growth factors influencing this market include the rising demand for biopharmaceuticals due to increasing instances of chronic diseases and a growing focus on personalized medicine. Technological advancements in bioprocessing equipment, along with innovations in single-use systems, have also propelled market growth by offering more flexible, cost-effective, and scalable solutions. The latest potential opportunities lie in emerging markets with growing healthcare infrastructures and in the development of novel biosimilars and biologics. However, challenges such as high initial capital investment, stringent regulatory requirements, and complex manufacturing processes pose significant limitations to market expansion. Areas ripe for innovation include the development of efficient downstream processing techniques, improvements in process analytical technologies (PAT), and advancements in biologic production efficiency through synthetic biology. Research into automation and digitalization within fermentation processes also offers pathways for business growth. The market is dynamic, characterized by rapid technological advancements and a competitive landscape with key players investing heavily in R&D. Businesses can capitalize on these trends by focusing on developing more sustainable and efficient fermentation processes, thereby aligning with the industry's shift toward more eco-friendly biomanufacturing practices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopharmaceutical Fermentation System Market

The Biopharmaceutical Fermentation System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing demand for biotech based drugs
  • Increasing incidences of chronic diseases
  • Development in industrial measurement and monitoring technologies for bio-based production processes
• Market Restraints
  • High cost related with the manufacturing and stringent regulatory requirements
• Market Opportunities
  • New innovations to make efficient and cost-effective fermentation systems
  • Increasing research and developmental activities in different fields of fermentation technology
• Market Challenges
  • Limited awareness and trained professionals in the field for biopharmaceutical fermentation systems

Porter's Five Forces: A Strategic Tool for Navigating the Biopharmaceutical Fermentation System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopharmaceutical Fermentation System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopharmaceutical Fermentation System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopharmaceutical Fermentation System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopharmaceutical Fermentation System Market

A detailed market share analysis in the Biopharmaceutical Fermentation System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopharmaceutical Fermentation System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopharmaceutical Fermentation System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biopharmaceutical Fermentation System Market

A strategic analysis of the Biopharmaceutical Fermentation System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Fermentation System Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., AntoXa Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioPharm Process Associates, LLC, Danaher Corporation, Eppendorf SE, F. Hoffmann-La Roche AG, GEA Group Aktiengesellschaft, General Electric Company, Lonza Group, Merck KGaA, Nova Biomedical Corporation, Sartorius AG, Thermo Fisher Scientific Inc., and ZETA GmbH.

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Fermentation System Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Downstream Process Product and Upstream Process Product. The Downstream Process Product is further studied across Chromatography Systems, Consumables & Accessories, and Filtration & Separation Instruments. The Upstream Process Product is further studied across Bioreactors or Fermenters, Buffers, Media & Culture Preparation, and Process Monitoring Systems.
• Based on Application, market is studied across Antibiotics, Monoclonal Antibodies, Probiotics, and Recombinant Proteins.
• Based on End User, market is studied across Biopharmaceutical Companies, Contract Research Organizations, Food Industry, and Research & Development Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing demand for biotech based drugs
    • 5.1.1.2. Increasing incidences of chronic diseases
    • 5.1.1.3. Development in industrial measurement and monitoring technologies for bio-based production processes
  • 5.1.2. Restraints
    • 5.1.2.1. High cost related with the manufacturing and stringent regulatory requirements
  • 5.1.3. Opportunities
    • 5.1.3.1. New innovations to make efficient and cost-effective fermentation systems
    • 5.1.3.2. Increasing research and developmental activities in different fields of fermentation technology
  • 5.1.4. Challenges
    • 5.1.4.1. Limited awareness and trained professionals in the field for biopharmaceutical fermentation systems
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biopharmaceutical Fermentation System Market, by Product

• 6.1. Introduction
• 6.2. Downstream Process Product
  • 6.2.1. Chromatography Systems
  • 6.2.2. Consumables & Accessories
  • 6.2.3. Filtration & Separation Instruments
• 6.3. Upstream Process Product
  • 6.3.1. Bioreactors or Fermenters
  • 6.3.2. Buffers
  • 6.3.3. Media & Culture Preparation
  • 6.3.4. Process Monitoring Systems

7. Biopharmaceutical Fermentation System Market, by Application

• 7.1. Introduction
• 7.2. Antibiotics
• 7.3. Monoclonal Antibodies
• 7.4. Probiotics
• 7.5. Recombinant Proteins

8. Biopharmaceutical Fermentation System Market, by End User

• 8.1. Introduction
• 8.2. Biopharmaceutical Companies
• 8.3. Contract Research Organizations
• 8.4. Food Industry
• 8.5. Research & Development Institutes

9. Americas Biopharmaceutical Fermentation System Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Biopharmaceutical Fermentation System Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Biopharmaceutical Fermentation System Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. AntoXa Corporation
• 3. Becton, Dickinson and Company
• 4. Bio-Rad Laboratories, Inc.
• 5. BioPharm Process Associates, LLC
• 6. Danaher Corporation
• 7. Eppendorf SE
• 8. F. Hoffmann-La Roche AG
• 9. GEA Group Aktiengesellschaft
• 10. General Electric Company
• 11. Lonza Group
• 12. Merck KGaA
• 13. Nova Biomedical Corporation
• 14. Sartorius AG
• 15. Thermo Fisher Scientific Inc.
• 16. ZETA GmbH